Every year 5,000 men may face unnecessary Overn for prostate cancer Due to the ‘old’ guidelines, a charity has warned.
Overtory of the disease can cause side effects such as erectile dysfunction or incontinence prostate cancer UK.
Cancer of patients Progress is unlikely, only close monitoring may be required. , NHS,
The warning comes when the government is currently waiting for advice on a national screening program for prostate cancerWhich was launched after the head Chris HoyAfter surfaced in February 2024, a call was made for more men to be called that they were detected of stage for prostate cancer.
One of the four of the four of prostate cancer diagnosed will have a cancer that is so slow that it is never likely to harm.
Good guidance currently recommends active monitoring as a preferred approach to men who have the lowest risk cancer. But these guidelines have not been updated since 2021, and prostate cancer UK argues that they do not take into account advances in testing and diagnosis.
Professor Professor Vincent Gyanpragasam, Professor of Urology at Cambridge University said: ,Active monitoring is the best treatment option for men whose cancer is unlikely or they are unlikely to cause problems in their lifetime.
“But the old guidelines of Nice have created a depth about wild waste how monitoring by various health care teams. As a result of this incompatibility, there is a lack of confidence from patients under monitoring, which can be selected for treatment inste
According to charity, the overtreatment rate in England ranges from 2 to 24 percent, and warns that it results in a “postcode lottery” in which some men receive unnecessarily treatment while others receive monitoring because they should be. It was also found that 35 hospitals have made their own guidelines as to what to do.
Michael Lewis, 6, 63, revealed prostate cancer in 2020. The nurse said to Dadle., “My doctors told me that my cancer was ‘low risk’ and was unlikely to spread quickly, so I was kept under active monitoring until 2024, when my PSA level started growing again, so I underwent surgery to remove my prostate.
“Being on active monitoring meant that I did not need to treat until I needed. I was able to continue my everyday life without any side effects. I am happy that when I needed it, I was able to get treatment, but the time was so valuable without it.”
Amy Raylance, Assistant Director of Health Improvement in Prostate Cancer UK, said: “Thanks to advances in research, we can now tell which prostate cancer needs immediate treatment, and which men would be better than monitoring with blood tests and scans – they will be able to delay or even avoid completely treatment.”
He said that the treatment for prostate cancer, such as radiotherapy or surgery, may be “life -changing side effects, such as incontinence or erectile dysfunction, which can have a large mental and physical effect on men”.
He said, “The probability of men who experience these life -changing side effects under the old guidance of NICE are increasing,” he said. “It is creating confusion and incompatibility between hospitals how active monitoring in England is that the postcode of overtreatment is a pioneer for lottery.”
Charity is now repeating its call to NICE to update its guidance on active monitoring, claiming that it can help 5,000 men to avoid overtreating in a year.
The UK’s National Screening Committee is currently assessing whether a national screening program for prostate cancer should be rolled out.
A good spokesperson said, “We are committed to ensuring that our guidelines continue to reflect the best available evidences and give patients the best possible results. They are developed by an independent committee, including NHS clinical experts, and placed under reviews to ensure that they remain current.
“We are updating our prostate cancer guidelines, including reviews of the recommendations around active monitoring, and will assess whether our suspected cancer guidelines require the referral to referral from primary care to threshold prostate cancer for age related to PSA tests around PSA tests around the recommendations.